A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 31 Mar 2017 Planned number of patients changed from 500 to 550.
- 31 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 May 2017.
- 28 Feb 2017 Planned number of patients changed from 200 to 500.